CIK: 0001595430 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $656,978 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 7,601,087 | $354,971 | 54.0% | $40.59 | -3.5% | COM | 76155X100 |
| ORIC | ORIC PHARMACEUTICALS INC | 7,162,637 | $85,952 | 13.1% | $8.21 | +28.1% | COM | 68622P109 |
| TYRA | TYRA BIOSCIENCES INC | 4,055,861 | $56,741 | 8.6% | $12.94 | -11.9% | COM | 90240B106 |
| TNGX | TANGO THERAPEUTICS INC | 5,533,980 | $46,485 | 7.1% | $2.46 | +175.6% | COM | 87583X109 |
| RLAY | RELAY THERAPEUTICS INC | 3,846,409 | $20,078 | 3.1% | $3.92 | -2.7% | COM | 75943R102 |
| KYMR | KYMERA THERAPEUTICS INC | 340,909 | $19,295 | 2.9% | $34.43 | +31.0% | COM | 501575104 |
| ZYME | ZYMEWORKS INC | 1,113,946 | $19,026 | 2.9% | $13.64 | +5.0% | COM | 98985Y108 |
| ARVN | ARVINAS INC | 1,408,394 | $12,000 | 1.8% | $15.67 | -51.6% | COM | 04335A105 |
| ALMS | ALUMIS INC | 2,915,998 | $11,635 | 1.8% | $5.28 | -21.9% | COM | 022307102 |
| CNTX | CONTEXT THERAPEUTICS INC | 7,419,355 | $7,188 | 1.1% | $0.87 | -6.9% | COM | 21077P108 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,141,145 | $6,767 | 1.0% | $9.60 | -23.7% | COM | 230031106 |
| SPRY | ARS PHARMACEUTICALS INC | 660,703 | $6,640 | 1.0% | $12.03 | +19.3% | COM | 82835W108 |
| SLN | SILENCE THERAPEUTICS PLC | 952,400 | $4,943 | 0.8% | $2.82 | — | ADS | 82686Q101 |
| — | MERSANA THERAPEUTICS INC | 482,689 | $3,746 | 0.6% | $7.76 | — | COM | 59045L205 |
| BOLD | BOUNDLESS BIO INC | 1,228,069 | $1,511 | 0.2% | $2.07 | -44.3% | COM | 10170A100 |